These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37090164)

  • 21. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Sutcliffe S; Grubb Iii RL; Platz EA; Ragard LR; Riley TL; Kazin SS; Hayes RB; Hsing AW; Andriole GL;
    BJU Int; 2012 Oct; 110(7):1050-9. PubMed ID: 22429766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment.
    Roehrborn CG; Egan KB; Miner MM; Ni X; Wong DG; Rosen RC
    BJU Int; 2016 Jul; 118(1):153-60. PubMed ID: 26765325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
    Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
    Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-world data and treatment patterns of patients with lower urinary tract symptoms due to benign prostatic hyperplasia in Germany: an observational study using health insurance claims data.
    Miernik A; Fritzsche J; Libutzki B; Malka V; Kilemnik I; Mohebbi D; May M; Gratzke C; Suarez-Ibarrola R
    World J Urol; 2021 Dec; 39(12):4381-4388. PubMed ID: 34292368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depressive males have higher odds of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a retrospective cohort study based on propensity score matching.
    Xiong Y; Zhang YC; Jin T; Qin F; Yuan JH
    Asian J Androl; 2021; 23(6):633-639. PubMed ID: 33818525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.
    Porpiglia F; Fiori C; Bertolo R; Garrou D; Cattaneo G; Amparore D
    BJU Int; 2015 Aug; 116(2):278-87. PubMed ID: 25382816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of Benign Prostate Hyperplasia Based on Magnetic Resonance Imaging Are Correlated With Lower Urinary Tract Symptoms and Continence in Men Undergoing a Robot-assisted Radical Prostatectomy for Prostate Cancer.
    Grivas N; van der Roest R; Tillier C; Schouten D; van Muilekom E; Schoots I; van der Poel H; Heijmink S
    Urology; 2017 Sep; 107():196-201. PubMed ID: 28601562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK.
    Speakman M; Kirby R; Doyle S; Ioannou C
    BJU Int; 2015 Apr; 115(4):508-19. PubMed ID: 24656222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
    Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
    J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship of depression, alcohol and marijuana with treatment for LUTS/BPH.
    Lloyd GL; Makedon AM; Marks JM; Wiesen B; Carmichael H
    Can J Urol; 2022 Aug; 29(4):11249-11254. PubMed ID: 35969729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relationship of socioeconomic factors with medical utilization for lower urinary tract symptoms and benign prostatic hyperplasia in a South Korean community].
    Kim HH; Kong KA; Lee HJ; Yoon H; Lee BE; Moon OR; Park H
    J Prev Med Public Health; 2006 Mar; 39(2):141-8. PubMed ID: 16615269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of increased urine brain derived neurotrophic factor with lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Wang LW; Li JL; Yu Y; Xiao RH; Huang HW; Kuang RR; Hai B
    J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):531-535. PubMed ID: 28786061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Rosen RC; Fitzpatrick JM;
    BJU Int; 2009 Oct; 104(7):974-83. PubMed ID: 19426189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced sleep duration increases the risk of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in middle-aged and elderly males: a national cross-sectional study.
    Xiong Y; Zhang Y; Zhang F; Wu C; Qin F; Yuan J
    Aging Male; 2022 Dec; 25(1):159-166. PubMed ID: 35635060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Reddy B; Shin TY; Kim MH; Narayan V; Dahm P
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012867. PubMed ID: 33368143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The long-term influence of vasectomy on prostatic volume and morphology in man.
    Jakobsen H; Torp-Pedersen S; Juul N; Hald T
    Prostate; 1988; 13(1):57-67. PubMed ID: 2458585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volume.
    Xia BW; Zhao SC; Chen ZP; Chen C; Liu TS; Yang F; Yan Y
    Prostate; 2020 May; 80(6):481-490. PubMed ID: 32104919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperlipidemia is associated with an increased risk of clinical benign prostatic hyperplasia.
    Shih HJ; Huang CJ; Lin JA; Kao MC; Fan YC; Tsai PS
    Prostate; 2018 Feb; 78(2):113-120. PubMed ID: 29119583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of sleep quality with lower urinary tract symptoms/benign prostatic hyperplasia among men in China: A cross-sectional study.
    Li Y; Zhou X; Qiu S; Cai B; Wang S; Chen L; Hu D; Jiang Z; Wang M; Xiong X; Jin K; Wei Q; Yang L; Ma L
    Front Aging Neurosci; 2022; 14():938407. PubMed ID: 36353690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.